Abstract
Purpose
Fluid management with body composition monitor based on bioimpedance spectroscopy (BCM-BIS) has been found to be beneficial for dialysis patients. We conducted a study to provide an algorithm for the determination of post-dialysis target weight (PDTW) and to evaluate whether this approach could improve clinical outcomes compared to patients who had PDTW decided clinically.
Methods
Two hundred and ninety-eight dialysis patients participated in this 1-year randomized controlled trial. The outcomes were all-cause hospitalization rate, AFO or CV-related events, hypertension and intra-dialysis morbidities.
Results
80 % of post-dialysis weight reached the target set with current algorithm. All-cause hospitalization rate was not different. Incidence of acute fluid overload (AFO) or CV-related events was lower in study group. Longitudinal data showed decreased incidence of hypertension, intra-dialysis morbidities and intra-dialysis hypotension.
Conclusions
Assessment of PDTW by BCM-BIS with an explicit algorithm decreased AFO or CV-related events, hypertension and intra-dialysis morbidities. Further studies were required to demonstrate possible benefits of hospitalization rate.
Similar content being viewed by others
References
Jaeger JQ, Mehta RL (1999) Assessment of dry weight in hemodialysis: an overview. J Am Soc Nephrol 10:392–403
Davenport A (2006) Intradialytic complications during hemodialysis. Hemodial Int 10:162–167
Charra B (2007) Fluid balance, dry weight, and blood pressure in dialysis. Hemodial Int 11:21–31
Moissl UM, Wabel P, Chamney PW et al (2006) Body fluid volume determination via body composition spectroscopy in health and disease. Physiol Meas 27:921–933
Chamney PW, Wabel P, Moissl UM et al (2007) A whole-body model to distinguish excess fluid from hydration of major body tissues. Am J Clin Nutr 85:80–89
Medrano G, Eitner F, Floege J, Leonhardt S (2010) A novel bioimpedance technique to monitor fluid volume state during hemodialysis treatment. ASAIO J 56:215–220
Wabel P, Moissl U, Chamney P et al (2008) Towards improved cardiovascular management: the necessity of combining blood pressure and fluid overload. Nephrol Dial Transplant 23:2965–2971
Wizemann V, Wabel P, Chamney P et al (2009) The mortality risk of overhydration in hemodialysis patients. Nephrol Dial Transplant 24:1574–1579
Chazot C, Wabel P, Chamney P, Moissl U, Wieskotten S, Wizemann V (2012) Importance of normohydration for the long-term survival of haemodialysis patients. Nephrol Dial Transplant 27:2404–2410
O’Lone EL, Visser A, Finney H, Fan SL (2014) Clinical significance of multi-frequency bioimpedance spectroscopy in peritoneal dialysis patients: independent predictor of patient survival. Nephrol Dial Transplant 29:1430–1437
Mamat R, Kong NC, Ba’in A et al (2012) Assessment of body fluid status in hemodialysis patients using the body composition monitor measurement technique. J Clin Nurs 21:2879–2885
Kuhlmann MK, Zhu F, Seibert E, Levin NW (2005) Bioimpedance, dry weight and blood pressure control: new methods and consequences. Curr Opin Nephrol Hypertens 14:543–549
Vujicic B, Mikolasevic I, Racki S, Orlic L, Ljutic D, Bubic I (2013) BCM - Body Composition Monitor: a New Tool for the Assessment of Volume-Dependent Hypertension in Patients on Maintenance Haemodialysis. Coll Antropol 37:815–819
Machek P, Jirka T, Moissl U, Chamney P, Wabel P (2010) Guided optimization of fluid status in hemodialysis patients. Nephrol Dial Transplant 25:538–544
Moissl U, Arias-Guillen M, Wabel P et al (2013) Bioimpedance-Guided Fluid Management in Hemodialysis Patients. Clin J Am Soc Nephrol 8:1575–1582
Onofriescu M, Hogas S, Voroneanu L et al (2014) Bioimpedance-guided fluid management in maintenance hemodialysis: a pilot randomized controlled trial. Am J Kidney Dis 64:111–118
Hur E, Usta M, Toz H et al (2013) Effect of Fluid Management Guided by Bioimpedance Spectroscopy on Cardiovascular Parameters in Hemodialysis Patients: a Randomized Controlled Trial. Am J Kidney Dis 61:957–965
Chen HS, Lee KC, Cheng CT et al (2013) Application of Bioimpedance Spectroscopy in Asian Dialysis Patients (ABISAD): serial follow-up and dry weight evaluation. Clin Kidney J 6:29–34
Woods HF (2014) 2013 Annual Medical Director’s Report for Dialysis Centers of NephroCare Asia Pacific. Report presented at NephroCare Taiwan Combined Meeting 2014; May 15, 2014; Taipei, Taiwan
Reddan DN, Szczech LA, Hasselblad V et al (2005) Intradialytic Blood Volume Monitoring in Ambulatory Hemodialysis Patients: a Randomized Trial. J Am Soc Nephrol 16:2162–2169
Wieskotten S, Heinke S, Wabel P et al (2007) Modell-basierte Erkennung vonMangelern¨ ahrungmittels Bioimpedanzspektroskopie. Automa- tisierungstechnik 10:531–538
Fotheringham J, Fogarty DG, El Nahas M, Campbell MJ, Farrington K (2015) The mortality and hospitalization rates associated with the long interdialytic gap in thrice-weekly hemodialysis patients. Kidney Int. doi:10.1038/ki.2015.141
Tsai YC, Chiu YW, Tsai JC et al (2015) Association of fluid overload with cardiovascular morbidity and all-cause mortality in stages 4 and 5 CKD. Clin J Am Soc Nephrol 10:39–46
Grundy SM, Benjamin IJ, Burke GL et al (1999) Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 100:1134–1146
Grundy SM (2006) Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol 47:1093–1100
West NA, Hamman RF, Mayer-Davis EJ et al (2009) Cardiovascular risk factors among youth with and without type 2 diabetes: differences and possible mechanisms. Diabetes Care 32:175–180
Ozkahya M, Ok E, Cirit M et al (1998) Regression of left ventricular hypertrophy in haemodialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs. Nephrol Dial Transplant 13:1489–1493
Ozkahya M, Toz H, Ozerkan F et al (2002) Impact of volume control on left ventricular hypertrophy in dialysis patients. J Nephrol 15:655–660
Ozkahya M, Ok E, Toz H et al (2006) Long-term survival rates in haemodialysis patients treated with strict volume control. Nephrol Dial Transplant 21:3506–3513
Agarwal R, Alborzi P, Satyan S, Light RP (2009) Dry-Weight Reduction in Hypertensive Hemodialysis Patients (DRIP): a randomized, controlled trial. Hypertension 53:500–507
Van de Kerkhof J, Hermans M, Beerenhout C, Konings C, Van der Sande FM, Kooman JP (2004) Reference values for multifrequency bioimpedance analysis in dialysis patients. Blood Purif 22:301–306
Acknowledgments
Special thanks are given to Dr. Michael Etter, Dr. Feidhlim Woods and G.M. Irene Feng for their robust support, precious opinions and efforts to encourage and organize the proceeding of this publication. This study was supported by NephroCare Asia Pacific, Taiwan Division (Grand No. 102030).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Neither Fresenius Medical Care (which markets the Body Composition Monitor) nor the sponsor had a role in study design and conduct; data management, collection, and analysis; or preparation and submission of the manuscript. All authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Huan-Sheng, C., Yeong-Chang, C., Ming-Hsing, H. et al. Application of bioimpedance spectroscopy in Asian dialysis patients (ABISAD-III): a randomized controlled trial for clinical outcomes. Int Urol Nephrol 48, 1897–1909 (2016). https://doi.org/10.1007/s11255-016-1415-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-016-1415-8